MCK May 2024 320.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 02:36PM EDT. Market open.
| Previous Close | 218.28 |
| Open | 218.28 |
| Bid | 221.10 |
| Ask | 231.00 |
| Strike | 320.00 |
| Expire Date | 2024-05-17 |
| Day's Range | 218.28 - 218.28 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
- Reuters
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged sales in its U.S. pharmaceutical segment. The segment also sells branded and generic drugs, as well as over-the-counter products and vaccines. Sales in the segment rose 11.5% in the fourth quarter to $68.79 billion, but missed analysts' estimate of $71.65 billion, according to LSEG data.
GuruFocus.comMcKesson Corp (MCK) Fiscal 2024 Earnings: Mixed Results Amidst Revenue Growth and Adjusted EPS ...
Insights into McKesson's Financial Performance and Future Outlook
ZacksMcKesson (MCK) Q4 Earnings and Revenues Lag Estimates
McKesson (MCK) delivered earnings and revenue surprises of -2.52% and 3%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.